Question special

Hello and welcome to the discussion of “Antenatal Betamethasone for Women at Risk for Late Preterm Delivery.” I want to thank Dr. Gyamfi-Bannerman and colleagues for this very interesting and important randomized trial and for participating in this conversation. And I want to extend an additional thank you to our experts for your thoughts over the next ten days.

To begin, I wonder what the authors and experts think about who the ideal candidate is for late preterm administration of betamethasone. Which patients should we be thinking about when we think about applying the results of this study?